more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men

October 2013

You'll hear more controversy over the long-term safety and benefits of testosterone replacement in middle-aged and older men.

Drug companies spend over $100 million/yr promoting these products.

But there's not much evidence of significant improvements with testosterone replacement...and even less evidence of long-term safety.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote